A microfluidic chip developed at the University of Michigan is among the best at capturing elusive circulating tumor cells from blood—and it can support the cells’ growth for further analysis.
The device, believed to be the first to pair these functions, uses the advanced electronics material graphene oxide. In clinics, such a device could one day help doctors diagnose cancers, give more accurate prognoses and test treatment options on cultured cells without subjecting patients to traditional biopsies.
“If we can get these technologies to work, it will advance new cancer drugs and revolutionize the treatment of cancer patients,” said Max Wicha, M.D., Distinguished Professor of Oncology and director of the U-M Comprehensive Cancer Center and co-author of a paper on the new device, published online this week in Nature Nanotechnology.
“Circulating tumor cells will play a significant role in the early diagnosis of cancer and to help us understand if treatments are working in our cancer patients by serving as a ‘liquid’ biopsy to assess treatment responses in real time,” said co-author Dr. Diane Simeone, the Lazar J. Greenfield Professor of Surgery at the U-M Medical School and director of the Translational Oncology Program.
“Studies of circulating tumor cells will also help us understand the basic biologic mechanisms by which cancer cells metastasize or spread to distant organs—the major cause of death in cancer patients.”
Yet these cells aren’t living up to their promise in medicine because they are so difficult to separate from a blood sample, the researchers say. In the blood of early-stage cancer patients, they account for less than one in every billion cells, so catching them is tougher than finding the proverbial needle in a haystack.
“I can burn the haystack or use a huge magnet,” said Sunitha Nagrath, an assistant professor of chemical engineering, who led the research. “When it comes to circulating tumor cells, they almost look like—feel like—any other blood cell.”
On their microfluidic chip, Nagrath’s team grew dense forests of molecular chains, each equipped with an antibody to grab onto cancer cells.
Even after the cells are caught, it’s still hard to run a robust analysis on just a handful of them, the researchers say. That’s why this demonstration of highly sensitive tumor cell capture, combined with the ability to grow the cells in the same device, is so promising.
Hyeun Joong Yoon, a postdoctoral researcher in the Nagrath lab with a background in electrical engineering, was instrumental in making the microfluidic chip. He started with a silicon base and added a grid of nearly 60,000 flat gold shapes, like four-petaled flowers, each no wider than a strand of hair.
The gold flowers naturally attracted a relatively new material called graphene oxide. These sheets of carbon and oxygen, just a few atoms thick, layered themselves over the gold. This layered formation allowed the team to grow the tumor-cell-catching molecular chains so densely.
“It’s almost like each graphene has many nano-arms to capture cells,” Nagrath said.
To test the device, the team ran one-milliliter samples of blood through the chip’s thin chamber. Even when they had added just three-to-five cancer cells to the 5-10 billion blood cells, the chip was able to capture all of the cells in the sample half the time, with an average of 73 percent over 10 trials.
“That’s the highest anybody has shown in the literature for spiking such a low number of cells,” Nagrath said.
The Latest Bing News on:
Liquid biopsy
- APCCC 2024: When to Do Tumor Genomic Profiling in Advanced Prostate Cancer and What?on April 26, 2024 at 3:55 pm
Advanced Prostate Cancer Consensus Conference (APCCC) meeting featured a session on the management of metastatic CRPC (mCRPC), and a presentation by Dr. Niven Mehra discussing when we should do tumor ...
- Sophia Genetics Announces Syndicate Bio As First Liquid Biopsy Customer In Africaon April 26, 2024 at 1:03 am
Boston, MA and Rolle, Switzerland, April 23, 2024 ndash; SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader i ...
- Medtech’s top executive moves in 2024on April 25, 2024 at 6:28 am
Philips, Illumina, Insulet and Exact Sciences have all gained new CFOs in recent weeks.
- Liquid biopsy firm Angle signs new commercial agreement with AstraZenecaon April 24, 2024 at 1:16 am
United Kingdom-based liquid biopsy company Angle (OTCQX:ANPCY) has signed a supplier agreement with the biopharmaceutical company AstraZeneca (NASDAQ:AZN) to tailor the existing Parsortix-based DNA ...
- SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africaon April 22, 2024 at 7:05 pm
Syndicate Bio to implement new liquid biopsy offering to advance cancer diagnostics throughout Africa BOSTON and ROLLE, Switzerland, April 23, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq ...
- New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomeson April 17, 2024 at 5:35 am
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to announce the Company has ...
- JCO Precision Oncology Conversationson April 16, 2024 at 5:01 pm
Dr. Christian Rolfo: Thank you very much, Rafeh. It's a pleasure to be here and discuss about liquid biopsy. Dr. Rafeh Naqash: You have a very important role in different liquid biopsy consortiums.
- Non-Invasive Liquid Biopsy Market CAGR of 15.7%, Size, Trends, Growth Status, Share, Research, and Forecast 2024 to 2032on April 16, 2024 at 2:06 pm
Liquid biopsy has emerged as a promising non-invasive technique for detecting and monitoring various types of cancers. Unlike traditional tissue biopsies, which often involve invasive procedures, ...
- There’s still no standard test to detect pancreatic cancer early. Scientists are working to change thaton April 8, 2024 at 8:31 am
Across the United States, research teams are investigating ways to spot early cases, with many turning to blood-based liquid biopsy tests. “This term ‘liquid biopsy,’ essentially ...
- An exosome-based liquid biopsy shows promise for early detection of pancreatic canceron April 7, 2024 at 5:00 pm
An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA 19-9, according to research presented at the American ...
The Latest Google Headlines on:
Liquid biopsy
[google_news title=”” keyword=”Liquid biopsy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Diagnosing cancers
- Charles is returning to public duties today for first time since his cancer diagnosis as Harry prepares for solo visiton April 29, 2024 at 11:36 pm
KING Charles is set to officially return to public duties today alongside Queen Camilla for the first time since his cancer diagnosis. The monarch, 75, will be visiting a cancer treatment centre to ...
- What’s behind the rise in colon cancer among young people?on April 29, 2024 at 11:21 pm
With more and more people below the age of 50 being diagnosed with the illness, the medical community is urgently trying to determine a cause.
- EastEnders’ Cheryl Fergison set for TV comeback after heartbreaking cancer diagnosison April 29, 2024 at 10:59 pm
EastEnders legend Cheryl Fergison has teased a possible return to the BBC soap 10 years after her character Heather Trott was killed off on the show after being bludgeoned to death ...
- King returns to official public duties for first time since cancer diagnosison April 29, 2024 at 10:24 pm
The King is returning to public duties for the first time since his cancer treatment. On Friday, the palace announced that the King was "greatly encouraged" to be given the green light by doctors to ...
- Cancer in prison: barriers and enablers to diagnosis and treatmenton April 29, 2024 at 8:14 pm
Our findings demonstrate the complexity of cancer care in custodial settings, identifying barriers and enablers to equitable cancer care provision and offering insights on how to improve care for this ...
- Robotics could help diagnose and treat lung cancer in one procedureon April 29, 2024 at 7:59 pm
There are hopes that lung cancer could be diagnosed and removed from patients in one sitting in the future thanks to robotics, according to medics trialling the technology. The method allows doctors ...
- Former Uruguayan President Jose Mujica announces esophageal cancer diagnosison April 29, 2024 at 4:54 pm
Former Uruguayan President Jose Mujica, a left-wing power figurehead and ex-guerilla, announced Monday that he has been diagnosed with esophageal cancer.
- Iconic former Uruguayan President Jose Mujica is diagnosed with esophageal canceron April 29, 2024 at 3:31 pm
Uruguay’s former guerilla-turned-president, Jose Mujica, widely known as a leftist icon who transformed his small country into one of the most socially liberal in all of Latin America, said Monday ...
- Uruguay ex-president Jose Mujica diagnosed with 'challenging' canceron April 29, 2024 at 12:20 pm
Jose Mujica, Uruguay's former president and one of Latin America's best-known leaders, announced a cancer diagnosis on Monday that doctors say will be challenging to treat.
- Prince William, Kate Middleton mark 13th anniversary with never-before-seen wedding photoon April 29, 2024 at 10:12 am
Prince William and Kate, the Princess of Wales, are celebrating their 13th wedding anniversary. The couple, who wed on April 29, 2011, marked the occasion publicly by sharing on social media a ...
The Latest Google Headlines on:
Diagnosing cancers
[google_news title=”” keyword=”diagnosing cancers” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]